Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannes Alber

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|February 1, 2013
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillationThomas Berger, Hannes Alber
Heart (British Cardiac Society)|May 26, 2012
Is RAMIT reflecting the real world?Thomas Berger, Christian Brenneis, Hannes Alber
Journal of Cardiology Cases|May 11, 2026
Thrombocytosis-associated ticagrelor non-responder status after ECMO-supported primary PCI in STEMIChristoph Strohhofer, Hannes Alber, Jakob Dörler
International Journal of Cardiology|August 6, 2013
Post-interventional cardiac biomarker release has lower prognostic relevance compared with standard risk markers in patients with stable coronary artery disease undergoing elective percutaneous coronary interventionsMark Brauer, Edmund Bode, Bernhard Metzler, et al.
Wiener Klinische Wochenschrift|November 2, 2004
Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosisClemens Molnar, Hannes Alber, Daniela Colleselli, et al.
Coronary Artery Disease|December 14, 2011
Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factorsEdmund Bode, Thomas Wuppinger, Thomas Bode, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 20, 2020
The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteriaMarcel Razpotnik, Simona Bota, Philipp Wimmer, et al.
The American Journal of Cardiology|July 11, 2006
Comparison of three-dimensional imaging to transesophageal echocardiography for preoperative evaluation in mitral valve prolapseSilvana Müller, Ludwig Müller, Günther Laufer, et al.
Wiener Medizinische Wochenschrift (1946)|March 16, 2010
[Health-related quality of life, anxiety and depression before and after coronary artery bypass grafting]Nicole Pfaffenberger, Stephan Doering, Pamela Puffinger, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 11, 2015
CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized MedicineMartin Klieber, Herbert Oberacher, Silvia Hofstaetter, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|February 1, 2013
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillationThomas Berger, Hannes Alber
Heart (British Cardiac Society)|May 26, 2012
Is RAMIT reflecting the real world?Thomas Berger, Christian Brenneis, Hannes Alber
Journal of Cardiology Cases|May 11, 2026
Thrombocytosis-associated ticagrelor non-responder status after ECMO-supported primary PCI in STEMIChristoph Strohhofer, Hannes Alber, Jakob Dörler
International Journal of Cardiology|August 6, 2013
Post-interventional cardiac biomarker release has lower prognostic relevance compared with standard risk markers in patients with stable coronary artery disease undergoing elective percutaneous coronary interventionsMark Brauer, Edmund Bode, Bernhard Metzler, et al.
Wiener Klinische Wochenschrift|November 2, 2004
Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosisClemens Molnar, Hannes Alber, Daniela Colleselli, et al.
Coronary Artery Disease|December 14, 2011
Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factorsEdmund Bode, Thomas Wuppinger, Thomas Bode, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 20, 2020
The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteriaMarcel Razpotnik, Simona Bota, Philipp Wimmer, et al.
The American Journal of Cardiology|July 11, 2006
Comparison of three-dimensional imaging to transesophageal echocardiography for preoperative evaluation in mitral valve prolapseSilvana Müller, Ludwig Müller, Günther Laufer, et al.
Wiener Medizinische Wochenschrift (1946)|March 16, 2010
[Health-related quality of life, anxiety and depression before and after coronary artery bypass grafting]Nicole Pfaffenberger, Stephan Doering, Pamela Puffinger, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 11, 2015
CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized MedicineMartin Klieber, Herbert Oberacher, Silvia Hofstaetter, et al.
Pageof 5